AUTL Autolus Therapeutics plc Quarterly EPS earnings growth

Official company branding of Autolus Corp (AUTL)

Autolus Therapeutics (AUTL) develops T-cell therapy at its own facilities while outsourcing final trials to external partners. The quarterly EPS growth illustrates the profitability trend, where the current parameter equals 30.30. However, manufacturing complexities and intense competition create certain threats. The company is currently scaling deliveries to clinics, which is gradually offsetting previous R&D expenditures.

Autolus Therapeutics plc (AUTL) Year-over-year earnings per share growth for the last twelve months: for the period 07/04/2022 - 11/14/2026

Autolus Therapeutics (AUTL) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price Autolus Corp|AUTL - Consensus Target
- market capitalization data:
Market Capitalization Autolus Pharma|AUTL - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Autolus Therapeutics|AUTL - Company Book Value|Market Value to Book Value Ratio autolus.com|AUTL - Aggregate Company Assets
- company liabilities and liquidity data:
Total Debt to Equity Ratio Autolus Therapeutics|AUTL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital autolus.com|AUTL - Company Total Indebtedness|Debts to Book Capitalization Autolus Pharma|AUTL - Long-Term Debt|Company Short-Term Debt Autolus Therapeutics|Quick Ratio autolus.com
- earnings and market multiples details:
AUTL - Company Net Income|Future Profit Autolus Therapeutics|AUTL - Company Value to Net Income|Projected Price to Earnings Autolus Pharma|AUTL - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Autolus Therapeutics plc|AUTL - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Autolus Therapeutics|AUTL - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months autolus.com|AUTL - Earnings per share increase in current year|Earnings growth forecast for next year Autolus Therapeutics
- sales volume and revenue information:
AUTL - Revenue and Sales Volume|Company Projected Revenue Autolus Therapeutics plc|AUTL - Price-to-Sales Ratio|Forward Price-to-Revenue Multiple Autolus Pharma
Fundamental company analysis:autolus.com - AUTL
Finished products of Autolus Corp

This indicator measures the quarterly dynamics of net earnings per share. This metric allows for an assessment of capital management efficiency and business scaling rates. By analyzing the quarterly change in earnings per share, an investor determines the issuer's resilience to market shocks. For Autolus Therapeutics (AUTL), such dynamics reflect the impact of obe-cel production automation on cost reduction. The platform's technological advantage directly translates into increased financial returns.

Analysis of competing companies

LEGN: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Sana Bio|ALLO (Allogene Therapeutics, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months selectabio.com RNAC|Year-over-year earnings per share growth for the last twelve months Cellectis (CLLS)|Year-over-year earnings per share growth for the last twelve months CRBU (Caribou Biosciences Inc.)|Instil Bio, Inc - Year-over-year net earnings per share growth for the last 12 months|genenta.com - Year-over-year earnings per share growth for the last twelve months|IPSC: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months JSPR (jaspertherapeutics.com)|SNTI: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Adaptimmune Therapeutics plc ADAP|CERO (CERo Therapeutics Holdings, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months alaunos.com TCRT|Year-over-year earnings per share growth for the last twelve months Achilles Tx (ACHL)|CARGO Therapeutics - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth PSTX (Poseida Corp)|2seventy Bio (TSVT) - Earnings per share growth in annualized terms for the last twelve months|GRCL: Year-over-year net earnings per share growth for the last 12 months